ALI WHITTEN: Open Payments
NPI 1174952014 · TRAVELERS REST, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 55 payments from 17 companies in 2025. Trend: 2023 $1,013 · 2024 $1,225 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $228 |
| ABBVIE INC. | 15 | $152 |
| Lundbeck LLC | 8 | $144 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Amgen Inc. | 3 | $48 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| PFIZER INC. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $33 |
| Alkermes, Inc. | 1 | $28 |
Products named: CAPLYTA, REXULTI, VRAYLAR, LAGEVRIO, UBRELVY, XIFAXAN, JARDIANCE, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
